Has David Kaplan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,353 in general payments to David Kaplan, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Kaplan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Kaplan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Kaplan, MD

Vascular Surgery · Slidell, LANPI 1558310862

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $7,743 and has fallen 89.3% since, to $831 in 2025.

$13,353in general payments, 2019–2025

Across 123 payments — averaging $108.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$8K
Silk Road Medical, Inc.$3K
W. L. Gore & Associates, Inc.$575
Globus Medical$447
Endologix LLC$294
Shockwave Medical, Inc$277
plus $1K from 25 others

What the payments were for

Consulting fees$7005%
Travel & lodging$7,33555%
Food & beverage$5,26839%
Education$500%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	28	$8,025
Silk Road Medical, Inc.	29	$2,508
W. L. Gore & Associates, Inc.	13	$575
Globus Medical	1	$447
Endologix LLC	3	$294
Shockwave Medical, Inc	2	$277
Philips North America LLC	5	$251
Penumbra, Inc.	6	$119
Stryker	1	$113
Boston Scientific	5	$103
Cardiovascular Systems Inc.	2	$81
Johnson & Johnson	5	$80
Lemaitre Vascular, Inc.	3	$58
Cvrx, Inc.	1	$47
Terumo Medical Corporation	2	$37
Bard Peripheral Vascular, Inc.	1	$37
Tactile Systems Technology Inc	2	$30
Dilon Technologies, Inc.	1	$27
Cook Medical LLC	1	$26
Teleflex LLC	1	$24
Abbott	1	$22
Pacira Pharmaceuticals Incorporated	1	$21
Kestra Medical Technology Services, Inc.	1	$20
Paratek Pharmaceuticals, Inc.	1	$20
Convatec Inc.	1	$19
Bolton Medical Inc	1	$18
KCI USA, Inc.	1	$17
Artivion, Inc.	1	$14
Davol Inc.	1	$14
Chiesi USA, Inc.	1	$13
Biocompatibles, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,353 in reported general payments places this provider in the 70th percentile of 65 vascular surgery providers in Louisiana.

See all vascular surgery providers in Louisiana →

Medicare billing

Part B allowed, 2024

$189,780

Medicare patients

413

Services billed

914

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	21	$11,811
Cilostazol	238	$3,818
ClopidogrelClopidogrel Bisulfate	184	$1,440
Pentoxifylline	36	$796
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	80	$490
Oxycodone Hcl	14	$53

Paid to pharmacies, not to this prescriber.